Clincosm LogoSign in Get a demo

glioblastoma

Showing 51 - 75 of 659
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Through Preservation of Biologically Active Brain

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Specimen Collection
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 24, 2023

Glioblastoma Trial in San Francisco (Cannabidiol (CBD), Placebo)

Not yet recruiting
  • Glioblastoma
  • Cannabidiol (CBD)
  • Placebo
  • San Francisco, California
    University of California San Francisco Brain Tumor Center
Feb 21, 2023

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Glioblastoma Trial in Valladolid (GTR surgery, AI-guided surgery)

Recruiting
  • Glioblastoma
  • GTR surgery
  • AI-guided surgery
  • Valladolid, Spain
    University Hospital Rio Hortega
Feb 21, 2023

Experiences of Glioblastoma Patients

Not yet recruiting
  • Glioblastoma
    • (no location specified)
    Feb 4, 2023

    Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

    Recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Biopsy
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Feb 2, 2023

    Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

    Recruiting
    • Glioblastoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

    Recruiting
    • Diffuse Astrocytoma
    • +22 more
    • Phoenix, Arizona
    • +26 more
    Jan 27, 2023

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Glioblastoma Trial in Boston (ITI-1001)

    Not yet recruiting
    • Glioblastoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 13, 2023

    Glioblastoma Trial in Birmingham (Point-of-care Portable Perfusion Phantom (P4))

    Recruiting
    • Glioblastoma
    • Point-of-care Portable Perfusion Phantom (P4)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 24, 2023

    Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

    Recruiting
    • Glioblastoma
    • Pembrolizumab and Temozolomide
    • Louisville, Kentucky
      James Graham Brown Cancer Ctr.
    Jan 18, 2023

    Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

    Terminated
    Has Results
    • Glioblastoma
    • Glioma
    • Boston, Massachusetts
    • +5 more
    Jan 24, 2023

    Standard Radiotherapy and TMZ Patients With GBM

    Not yet recruiting
    • Glioblastoma
    • Glioma, Malignant
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke University
      Jan 20, 2023

      Glioblastoma Trial in France, Portugal, Spain ([177Lu]Lu-DOTA-TATE, [68Ga]Ga-DOTA-TATE, Temozolomide)

      Recruiting
      • Glioblastoma
      • Bron, France
      • +8 more
      Jan 23, 2023

      Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

      Recruiting
      • Astrocytoma, Grade IV
      • +3 more
      • CYNK-001 systemic and Intra cavity administration
      • Duarte, California
      • +5 more
      Jan 20, 2023

      Brain Tumor Trial in Baltimore, Rochester (Exablate Model 4000)

      Recruiting
      • Glioblastoma
      • +2 more
      • Focused Ultrasound (Exablate Model 4000)
      • Miami, Florida
      • +5 more
      Jan 18, 2023

      Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

      Recruiting
      • Glioblastoma
      • +3 more
      • Nivolumab-Placebo
      • +4 more
      • Los Angeles, California
      • +3 more
      Jan 16, 2023

      Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

      Recruiting
      • Malignant Glioma of Brain
      • +8 more
      • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
      • Detroit, Michigan
        Henry Ford Health System
      Jan 9, 2023

      Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

      Active, not recruiting
      • Glioblastoma
      • Recurrent Glioblastoma
      • Boston, Massachusetts
      • +3 more
      Jan 13, 2023

      Glioblastoma Trial in Cleveland (NICO Myriad and Tissue Preservation System (TPS))

      Active, not recruiting
      • Glioblastoma
      • NICO Myriad and Tissue Preservation System (TPS)
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
      Jan 13, 2023

      Response and Progression in Glioblastoma

      Terminated
      • Glioblastoma
      • Glioblastoma Multiforme
      • MRI
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Jan 12, 2023

      Glioblastoma, Astrocytoma, Venous Thromboembolism Trial (Apixaban)

      Not yet recruiting
      • Glioblastoma
      • +2 more
      • (no location specified)
      Jan 4, 2023

      Glioblastoma Trial (Ipilimumab)

      Recruiting
      • Glioblastoma
      • Aberdeen, United Kingdom
      • +3 more
      Jan 12, 2023